OCTOBER 2022LIFE SCIENCES REVIEW522Partnering with a CDMO for successful late phase biologic drug product development and launchRoman Mathaes, Head of Pharmaceutical Services and Cristina Grigore, Technical Proposal Manager, LonzaRevolutionizingGenome Editing with CRISPRMark Behlke, CSO, Integrated DNA TechnologiesImprovements in Insulin Delivery Over Time and Expectations for the Future.Jesper Lekdorf, MD, Sr. Medical Director, Head of Medical Affairs, Novo Nordisk Japan20How Recent Technology Transformations in Pharma Analytics Impact BusinessSilji Abraham, Senior Vice President & Chief Digital and Transformation Officer, West Pharmaceutical Services2628How Allogeneic Stem Cell Therapies Can Transform Prospects in Inherited Retinal DiseasesGil Carrasquinho, VP Head of Cell Therapy, Santen08IN MY OPINIONCXO INSIGHTSCONTENTSU-MedicoFrontage Labs
< Page 4 | Page 6 >